Language Select
Varian Logo

Press Releases

August 08, 2019
This afternoon, Varian (NYSE: VAR) posted a presentation providing an overview of the recently proposed radiation oncology alternative payment model and calendar year 2020 rates by the Center for... Read more
August 08, 2019
Varian (NYSE: VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday,... Read more
August 05, 2019
Varian (NYSE: VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the... Read more
July 29, 2019
Following a public competitive review process, Varian (NYSE: VAR) was selected to supply its Eclipse™ treatment planning software and ARIA® oncology information system to three radiotherapy... Read more
July 25, 2019
Varian (NYSE: VAR) announced that the Karolinska University Hospital Solna in Sweden is the first hospital in Scandinavia to deliver High Dose Rate (HDR) brachytherapy treatments using the new... Read more
July 24, 2019
Third Quarter 2019 Summary Oncology Systems gross orders grew 2% in dollars, or 4% in constant currency; Trailing twelve months gross orders grew 11% in dollars, or 13% in constant currency Total... Read more
July 11, 2019
Varian (NYSE: VAR) today announced it will be showcasing systems and software from its cancer care portfolio, including the IDENTIFY™ Guidance System, at the American Association of Physicists... Read more
July 09, 2019
Varian (NYSE: VAR) celebrated the installation of the cyclotron for its ProBeam® Compact single-room proton therapy system at the King Chulalongkorn Memorial Hospital in Bangkok, Thailand on June... Read more
July 08, 2019
Varian (NYSE: VAR) is working in partnership with the International Atomic Energy Agency (IAEA) to improve cancer treatment by helping hospitals around the world deliver more precise radiotherapy... Read more
July 01, 2019
Varian (NYSE: VAR) today announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of microsphere and bland embolic bead products for treating... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations

Investor Relations Contact

Mike Bruff
SVP, Investor Relations